chr9-98831943-C-T
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_024642.5(GALNT12):c.903C>T(p.Pro301Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P301P) has been classified as Likely benign.
Frequency
Consequence
NM_024642.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- colorectal cancer, susceptibility to, 1Inheritance: AD Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GALNT12 | ENST00000375011.4 | c.903C>T | p.Pro301Pro | synonymous_variant | Exon 4 of 10 | 1 | NM_024642.5 | ENSP00000364150.3 | ||
| GALNT12 | ENST00000610463.1 | n.*334C>T | non_coding_transcript_exon_variant | Exon 3 of 4 | 4 | ENSP00000477657.1 | ||||
| GALNT12 | ENST00000610463.1 | n.*334C>T | 3_prime_UTR_variant | Exon 3 of 4 | 4 | ENSP00000477657.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152118Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000399 AC: 10AN: 250796 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000705 AC: 103AN: 1461566Hom.: 0 Cov.: 32 AF XY: 0.0000646 AC XY: 47AN XY: 727074 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74418 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at